X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Aventis Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs SANOFI INDIA - Comparison Results

SANOFI INDIA 
   Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. SANOFI INDIA FDC LTD./
SANOFI INDIA
 
P/E (TTM) x 28.9 33.7 86.0% View Chart
P/BV x 6.0 6.4 94.1% View Chart
Dividend Yield % 0.8 1.4 55.8%  

Financials

 FDC LTD.   SANOFI INDIA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
SANOFI INDIA
Dec-16
FDC LTD./
SANOFI INDIA
5-Yr Chart
Click to enlarge
High Rs1444,560 3.1%   
Low Rs794,400 1.8%   
Sales per share (Unadj.) Rs47.61,028.5 4.6%  
Earnings per share (Unadj.) Rs7.6129.0 5.9%  
Cash flow per share (Unadj.) Rs9.0186.0 4.8%  
Dividends per share (Unadj.) Rs2.2568.00 3.3%  
Dividend yield (eoy) %2.01.5 133.2%  
Book value per share (Unadj.) Rs47.5753.6 6.3%  
Shares outstanding (eoy) m177.8323.03 772.2%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.34.4 53.7%   
Avg P/E ratio x14.634.7 42.1%  
P/CF ratio (eoy) x12.324.1 51.3%  
Price / Book Value ratio x2.35.9 39.4%  
Dividend payout %29.652.7 56.1%   
Avg Mkt Cap Rs m19,784103,174 19.2%   
No. of employees `000NA3.6 0.0%   
Total wages/salary Rs m1,2213,592 34.0%   
Avg. sales/employee Rs ThNM6,537.7-  
Avg. wages/employee Rs ThNM991.4-  
Avg. net profit/employee Rs ThNM819.8-  
INCOME DATA
Net Sales Rs m8,45923,686 35.7%  
Other income Rs m394708 55.6%   
Total revenues Rs m8,85224,394 36.3%   
Gross profit Rs m2,0705,281 39.2%  
Depreciation Rs m2491,313 19.0%   
Interest Rs m3115 206.7%   
Profit before tax Rs m2,1844,661 46.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6061,691 35.8%   
Profit after tax Rs m1,3532,970 45.6%  
Gross profit margin %24.522.3 109.8%  
Effective tax rate %27.736.3 76.4%   
Net profit margin %16.012.5 127.6%  
BALANCE SHEET DATA
Current assets Rs m4,35515,673 27.8%   
Current liabilities Rs m1,7926,678 26.8%   
Net working cap to sales %30.338.0 79.8%  
Current ratio x2.42.3 103.6%  
Inventory Days Days4476 58.5%  
Debtors Days Days2522 110.5%  
Net fixed assets Rs m3,0258,098 37.4%   
Share capital Rs m179230 77.6%   
"Free" reserves Rs m8,24317,088 48.2%   
Net worth Rs m8,45317,356 48.7%   
Long term debt Rs m110-   
Total assets Rs m10,55725,400 41.6%  
Interest coverage x71.4311.7 22.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.9 85.9%   
Return on assets %13.111.8 111.6%  
Return on equity %16.017.1 93.5%  
Return on capital %23.526.9 87.3%  
Exports to sales %13.324.5 54.3%   
Imports to sales %3.328.0 11.9%   
Exports (fob) Rs m1,1265,801 19.4%   
Imports (cif) Rs m2836,627 4.3%   
Fx inflow Rs m1,1467,145 16.0%   
Fx outflow Rs m3556,846 5.2%   
Net fx Rs m791299 264.5%   
CASH FLOW
From Operations Rs m1,4853,226 46.0%  
From Investments Rs m-620-1,555 39.8%  
From Financial Activity Rs m-753-1,818 41.4%  
Net Cashflow Rs m113-147 -76.7%  

Share Holding

Indian Promoters % 68.9 0.0 -  
Foreign collaborators % 0.0 60.4 -  
Indian inst/Mut Fund % 4.7 14.4 32.6%  
FIIs % 7.5 14.6 51.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 10.5 181.0%  
Shareholders   23,730 15,184 156.3%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   ABBOTT INDIA  NATCO PHARMA  BIOCON LTD  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  

Compare FDC LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Continues Momentum; Metal Sector Up 2.5%(11:30 am)

After opening the day on a positive note, stock markets in India have continued their momentum. Sectoral indices are trading on a positive note with stocks in the metal sector.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Feb 23, 2018 12:39 PM

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE FDC LTD. WITH

MARKET STATS